1044872-40-3 Usage
Description
2-Amino-4,6-dichloro-nicotinicacidmethylester, also known as Methyl 2-Amino-4,6-dichloropyridine-3-carboxylate, is an organic compound with the chemical formula C7H6Cl2N2O2. It is a derivative of nicotinic acid, featuring a methyl ester group, two chlorine atoms at the 4 and 6 positions, and an amino group at the 2 position. 2-Amino-4,6-dichloro-nicotinicacidmethylester is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
2-Amino-4,6-dichloro-nicotinicacidmethylester is used as an intermediate in the synthesis of macrocyclic broad-spectrum antibiotics. These antibiotics are designed to target a wide range of bacterial infections, making them valuable in treating various diseases caused by different types of bacteria.
Used in Agrochemical Industry:
Although not explicitly mentioned in the provided materials, 2-Amino-4,6-dichloro-nicotinicacidmethylester may also have potential applications in the agrochemical industry. Given its structural features, it could be used as a precursor in the development of new pesticides or herbicides, contributing to more effective and targeted crop protection strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 1044872-40-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,4,8,7 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1044872-40:
(9*1)+(8*0)+(7*4)+(6*4)+(5*8)+(4*7)+(3*2)+(2*4)+(1*0)=143
143 % 10 = 3
So 1044872-40-3 is a valid CAS Registry Number.
1044872-40-3Relevant articles and documents
TYK2 INHIBITORS AND USES THEREOF
-
, (2020/06/10)
Described herein are compounds that are useful in treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation.
COMPOUNDS AND METHODS OF USE
-
, (2015/07/16)
This disclosure provides compounds and compositions and methods of using those compounds and compositions to treat diseases and disorders associated with excessive transforming growth factor-beta (TGFβ) activity. This disclosure also provides methods of using the compounds in combination with one or more cancer immunotherapies.
TREATMENT OF DISEASES BY EPIGENETIC REGULATION
-
, (2013/11/05)
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of diseases or disorders that are susceptible to administration of a BET inhibitor.